Related references
Note: Only part of the references are listed.Role of the Autonomic Nervous System in Modulating Cardiac Arrhythmias
Mark J. Shen et al.
CIRCULATION RESEARCH (2014)
Heart rate at baseline influences the effect of ivabradine on cardiovascular outcomes in chronic heart failure: analysis from the SHIFT study
Michael Boehm et al.
CLINICAL RESEARCH IN CARDIOLOGY (2013)
Resting, night-time, and 24 h heart rate as markers of cardiovascular risk in middle-aged and elderly men and women with no apparent heart disease
Christine D. Johansen et al.
EUROPEAN HEART JOURNAL (2013)
Impact of left bundle branch block on heart rate and its relationship to treatment with ivabradine in chronic heart failure
Jan-Christian Reil et al.
EUROPEAN JOURNAL OF HEART FAILURE (2013)
Efficacy and safety of ivabradine in chronic heart failure across the age spectrum: insights from the SHIFT study
Luigi Tavazzi et al.
EUROPEAN JOURNAL OF HEART FAILURE (2013)
Predictive value of night-time heart rate for cardiovascular events in hypertension. The ABP-International study
Paolo Palatini et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2013)
Safety of Ivabradine in Patients With Coronary Artery Disease and Left Ventricular Systolic Dysfunction (from the BEAUTIFUL Hotter Substudy)
Michal Tendera et al.
AMERICAN JOURNAL OF CARDIOLOGY (2011)
Effects of selective heart rate reduction with ivabradine on left ventricular remodelling and function: results from the SHIFT echocardiography substudy
Jean-Claude Tardif et al.
EUROPEAN HEART JOURNAL (2011)
Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study
Karl Swedberg et al.
LANCET (2010)
Heart rate as a risk factor in chronic heart failure (SHIFT): the association between heart rate and outcomes in a randomised placebo-controlled trial
Michael Boehm et al.
LANCET (2010)
Beneficial effects of delayed ivabradine treatment on cardiac anatomical and electrical remodeling in rat severe chronic heart failure
Paul Milliez et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2009)
Hospitalizations After Heart Failure Diagnosis A Community Perspective
Shannon M. Dunlay et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2009)
Predictive value of ambulatory heart rate in the Japanese general population: the Ohasama study
Atsushi Hozawa et al.
JOURNAL OF HYPERTENSION (2008)
Ivabradine for patients with stable coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a randomised, double-blind, placebo-controlled trial
Kim Fox et al.
LANCET (2008)
Heart rate as a prognostic risk factor in patients with coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a subgroup analysis of a randomised controlled trial
Kim Fox et al.
LANCET (2008)
Blunted heart rate dip during sleep and all-cause mortality
Iddo Z. Ben-Dov et al.
ARCHIVES OF INTERNAL MEDICINE (2007)
Preservation of coronary reserve by ivabradine-induced reduction in heart rate in infarcted rats is associated with decrease in perivascular collagen
Eduard I. Dedkov et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2007)
Efficacy of ivabradine, a new selective If inhibitor, compared with atenolol in patients with chronic stable angina
JC Tardif et al.
EUROPEAN HEART JOURNAL (2005)
Changes in heart rate variability are correlated to hemodynamic improvement with chronic CARVEDILOL therapy in heart failure
JR Bullinga et al.
JOURNAL OF CARDIAC FAILURE (2005)
Heart rate lowering by specific and selective I-f current inhibition with ivabradine - A new therapeutic perspective in cardiovascular disease
D DiFrancesco et al.
DRUGS (2004)
Antianginal and antiischemic effects of ivabradine, an If inhibitor, in stable angina -: A randomized, double-blind, multicentered, placebo-controlled trial
JS Borer et al.
CIRCULATION (2003)
Predictive value of clinic and ambulatory heart rate for mortality in elderly subjects with systolic hypertension
P Palatini et al.
ARCHIVES OF INTERNAL MEDICINE (2002)
Treatment of heart failure guided by plasma aminoterminal brain natriuretic peptide (N-BNP) concentrations
RW Troughton et al.
LANCET (2000)